BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 21325652)

  • 1. Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
    Caselli RJ; Dueck AC; Locke DE; Sabbagh MN; Ahern GL; Rapcsak SZ; Baxter LC; Yaari R; Woodruff BK; Hoffman-Snyder C; Rademakers R; Findley S; Reiman EM
    Neurology; 2011 Mar; 76(12):1078-84. PubMed ID: 21325652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers.
    Caselli RJ; Dueck AC; Locke DE; Hoffman-Snyder CR; Woodruff BK; Rapcsak SZ; Reiman EM
    Neurology; 2011 Apr; 76(16):1383-8. PubMed ID: 21502596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
    Caselli RJ; Dueck AC; Osborne D; Sabbagh MN; Connor DJ; Ahern GL; Baxter LC; Rapcsak SZ; Shi J; Woodruff BK; Locke DE; Snyder CH; Alexander GE; Rademakers R; Reiman EM
    N Engl J Med; 2009 Jul; 361(3):255-63. PubMed ID: 19605830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
    Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
    JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
    Caselli RJ; Reiman EM; Hentz JG; Osborne D; Alexander GE; Boeve BF
    Sleep; 2002 Jun; 25(4):447-53. PubMed ID: 12071547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
    Thambisetty M; Beason-Held L; An Y; Kraut MA; Resnick SM
    Arch Neurol; 2010 Jan; 67(1):93-8. PubMed ID: 20065135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.
    Caselli RJ; Graff-Radford NR; Reiman EM; Weaver A; Osborne D; Lucas J; Uecker A; Thibodeau SN
    Neurology; 1999 Jul; 53(1):201-7. PubMed ID: 10408560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
    Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
    Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropsychology of normal aging and preclinical Alzheimer's disease.
    Caselli RJ; Locke DE; Dueck AC; Knopman DS; Woodruff BK; Hoffman-Snyder C; Rademakers R; Fleisher AS; Reiman EM
    Alzheimers Dement; 2014 Jan; 10(1):84-92. PubMed ID: 23541188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
    Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
    Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
    Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
    Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
    Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
    Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study.
    Locke DE; Dueck AC; Stonnington CM; Knopman DS; Geda YE; Caselli RJ
    J Clin Psychiatry; 2013 Dec; 74(12):1256-61. PubMed ID: 24434095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Associations of Apolipoprotein E ε4 Genotype With Attentional Abilities Across the Life Span of Individuals With Down Syndrome.
    D'Souza H; Mason L; Mok KY; Startin CM; Hamburg S; Hithersay R; Baksh RA; Hardy J; Strydom A; Thomas MSC;
    JAMA Netw Open; 2020 Sep; 3(9):e2018221. PubMed ID: 32986108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.
    Thai C; Lim YY; Villemagne VL; Laws SM; Ames D; Ellis KA; Rainey-Smith SR; Martins RN; Masters CL; Rowe CC; Maruff P;
    PLoS One; 2015; 10(10):e0139082. PubMed ID: 26430784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course.
    Rawle MJ; Davis D; Bendayan R; Wong A; Kuh D; Richards M
    Transl Psychiatry; 2018 Jan; 8(1):18. PubMed ID: 29317609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.